Bio-Rad InteliQ Tumor Marker Control - HSA Registration DE0506892
Access comprehensive regulatory information for Bio-Rad InteliQ Tumor Marker Control in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0506892 and owned by Bio-Rad Laboratories Inc.. The device was registered on May 26, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
InteliQ Tumor Marker Control is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in the package insert. (AFP, Beta-2- Microglobulin, CA 125, CA15-3, CA 19-9, CA 27.29, CA 72-4, CEA, Cyfra 21-1, Ferritin, hCG, HE4 (Human Epididymis Protein 4, HER-2/neu, IFG- 1/Somatomedin C, ProGRP (Progastrin-Releasing Peptide), Prolactin, Prostatic Acid Phosphatase (PAP), PSA (Free), PSA (Total), Squamous Cell Carcinoma(SCC) and Thyroglobulin).